- Meeting abstract
- Open Access
Ebola virus: from in-situ simulation to SOP development
© Bredmose et al. 2015
- Published: 11 September 2015
- Personal Protection Equipment
- Crew Member
- Helicopter Emergency Medical Service
- Simulation Exercise
- Fidelity Simulation
Pre-hospital care (PHC) personnel can be exposed to patients with infections at any time. The recent epidemic of Ebola hemorrhagic fever has highlighted the need for guidelines (SOPs) and competence in handling patients with infectious diseases in a safe manner, for both patient and PHC crew. Low fidelity in situ simulation can be an effective tool for training crews and developing SOPs.
Three on call Helicopter Emergency Medical Service (HEMS) crews (HEMS physician, HEMS crew member and pilot) participated in a simulation exercise on management of a patient with potential symptoms of Ebola virus disease. A HEMS physician trained as a simulation training facilitator facilitated the simulation. Goals for the simulation exercises were: correct management of the patient, correct use of personal protection equipment (PPE), and team safety on scene. The HEMS crew provided feedback after the training on a standardised feedback form with closed questions using a 7 point Likert scale. During the debriefing the facilitator recorded important learning points that could be used to improve SOPs.
All crewmembers provided feedback after the training. All reported high degrees of satisfaction and realism within the simulation on a 7-pt. Likert scale. A total of 12 points of potential danger and the need for focused training were identified.
This resulted in the development of an improved SOP in the department. The teams involved agreed that simulation was a more efficient training method than traditional “PPE on/PPE off” training.
Low fidelity simulation with the on call HEMS crew is an effective way to combine relevant training with the development and improvement of SOPs in an area where there is little clinical experience.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.